Case study

Beneficial Ownership Concealed via PCC Structure

Critical Institution: International Private Wealth Jurisdiction: Channel Islands · Guernsey
UBO Resolution Complex Structures Sanctions & PEP Screening Jurisdictional Analysis KYC / EDD

Situation

A Guernsey Protected Cell Company with 17 protected cells was treated as a single entity for CDD. Standard due diligence assessed the wrapper, not the cells — so independent risk exposures inside individual cells were never surfaced.

Risk exposure

Three cells carried PEP connections invisible at entity level. One cell involved an Israeli minor beneficiary arrangement requiring specialist analysis. Internal teams had been unable to complete the UBO work for over two years.

Before & after — the numbers

17 cellsAnalysed independently
3PEP escalations surfaced
100%UBO resolved to natural person
6 weeksFrom stalled to regulator-ready

A Protected Cell Company is a single legal entity that behaves like many. Each cell is ring-fenced, with its own assets, its own beneficial owners, and potentially its own entirely different risk profile. Assess a PCC as one customer and the structure does exactly what its design allows: it lets a high-risk cell shelter behind a low-risk average.

That is what had happened here. A Guernsey PCC with seventeen cells had been onboarded and reviewed as a single entity, and the institution’s internal teams — competent, but without specialist structural expertise — had been unable to complete the beneficial-ownership work for more than two years.

Seventeen risks, not one

CCL approached the structure as what it economically was: seventeen separate risk assessments. We mapped the legal architecture cell by cell — establishing where control and benefit actually sat in each — and assessed each cell on its own jurisdictional, PEP and sanctions merits rather than absorbing it into an entity-level rating.

That cell-level analysis surfaced what the single-entity approach never could: three cells with PEP connections, and one cell involving an Israeli minor beneficiary arrangement that required specialist analysis and careful, defensible documentation rather than a standard template.

Resolution to the natural person

Each cell’s beneficial ownership was traced through its layers to identifiable natural persons, with the evidence and rationale documented at every step. The three PEP connections were escalated through a defined protocol. Within six weeks — against more than two years of internal stall — the portfolio reached 100% UBO resolution to natural-person level, fully re-documented and regulator-ready.

Why the structure beat standard CDD

The lesson generalises well beyond this client. PCCs, PAHVs and layered trust structures defeat template-driven diligence not because the diligence is careless but because it is aimed at the wrong unit. The risk lives in the layers. Surfacing it requires assessing each layer independently — the core of CCL’s UBO and complex-ownership work, and the subject of the UBO gap nobody is discussing.

Regulator-facing outputs

  • Full legal-structure map with control and benefit pathways
  • Cell-by-cell risk assessment and jurisdictional analysis
  • PEP escalations with documented rationale
  • Complete re-documentation and audit trail

Speak to the practice

Before it becomes a regulatory finding, make it a closed action.

A short, confidential advisory call to pressure-test where your KYC, AML, sanctions or risk-classification framework is exposed — and what a defensible fix looks like.